We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Doctors from Hong Kong, South Korea, Singapore and Malaysia have expressed concern that Western countries will get the majority of vaccines and other drugs needed to fight a potential avian flu pandemic.
Biologics contract manufacturer Omnia Biologics, Inc. (Omnia) (Rockville, MD) and Lentiviral vector manufacturer Lentigen Corp. (Baltimore, MD) today announced signing of a master services agreement for Omnia to provide Lentigen with access to its cGMP facilities and services.
Biotechnology companies Epimmune Inc and Immuno-Designed Molecules SA (IDM) have completed their merger to create IDM Pharma Inc (IDMI.O: Quote, Profile, Research), the companies said in a statement on Tuesday.
Debiopharm S.A., the independent drug development company specialising in oncology, endocrinology and niche products and DeveloGen AG, a biopharmaceutical company focusing on novel treatments for metabolic disorders, today announced an exclusive worldwide collaboration and licensing agreement, by which Debiopharm will develop PTR-262, a novel peptide drug for the treatment of myasthenia gravis (MG), before out-licensing to global partners for commercialisation.
Kosan Biosciences Inc. (KOSN.O: Quote, Profile, Research) said it terminated its previously announced 4.5 million common stock offering after the 17 percent decline in its stock earlier on Monday.
Acambis Plc, a U.K. maker of vaccines for anti-terrorism programs, is preparing a bid for a contract for supplying another 20 million doses of smallpox vaccine to the U.S. government.